Impact of medication dosage on Helicobacter pylori eradication rates among pediatric patients

Abstract

AbstractObjectivesHelicobacter pylori rates of eradication to common first‐line regimens continue to decline globally. Prescription of the appropriate medication dosage is an important consideration, particularly in the pediatric population due to medication weight‐based dosing. Limited data is available on the impact of guideline‐recommended weight‐based dosing on the successful eradication of H. pylori in children.MethodsRetrospective study of patients with histologic evidence of H. pylori from two pediatric tertiary care centers in New England. We excluded patients who were not treated or those missing eradication data. We compared the eradication rates of patients prescribed recommended weight‐based dosages, duration, and frequency of treatment with those who were not.ResultsOne hundred forty‐four patients were included. The overall eradication rate was 73.6% (106/144). All treatment regimens were properly prescribed for 14 days. There was a high rate of improper weight‐based dosing: proton pump inhibitor (PPI) 31.2% (45/144), amoxicillin 31.7% (39/123), metronidazole (MET) 19.4% (12/62), clarithromycin (CLA) 23.9% (22/70), tetracycline 50% (6/12), bismuth 26.1% (6/23). When PPIs were properly weight‐dosed, there was a 78.8% eradication rate that dropped to 62.2% with suboptimal dosing (p = 0.036, odds ratio [OR]: 2.26, confidence interval [CI]: 1.04−4.87). When amoxicillin was properly weight‐dosed, successful eradication was achieved in 81% versus only 53.8% when improperly dosed (p = 0.002; OR: 3.64, CI: 1.58−8.37). There was no statistically significant impact on eradication rates with improper weight‐based dosing of MET, CLA, tetracycline, or bismuth.ConclusionProper weight‐based dosing of amoxicillin and PPI is important for the successful eradication of H. pylori among children in the New England area.